In order to clarify the role of thrombin on the development of pulmonary fibrosis in diffuse interstitial lung diseases, we examined the relationship between fibroblast growth-stimulating activity (FGA) and thrombin activity in bronchoalveolar lavage fluid (BALF) from rats with bleomycin-induced interstitial lung disorders.
Male Wistar strain rats (body weight about 200g) were given a single intratracheal injection of 0.9mg bleomycin, and bronchoalveolar lavage was performed on days 2, 6 and 15. The BALF was centrifuged at 250×g for 10min to remove cells, and then the supernatant was recentrifuged at 27, 000×g for 40min to remove pulmonary surfactants. The supernatant (10ml) was dialyzed overnight against distilled water, frozen at -70°C, freeze-dried, and resuspended in 2ml of Dulbecco's modified Eagle medium (concentrated 5-fold). The 5-fold concentrated BALF was added to rat lung fibroblast culture media, and assayed for cytotoxic activity and FGA. Thrombin activity in 250×g supernatant was measured by using fluorescence assay with the synthetic peptide substrate, Boc-Val-Pro-Arg-4-methylcoumaryl-7-amide.
Histological examination showed a prominent increase in fibroblast number in the pulmonary interstitium on day 6, and transformation of fibroblasts into mature forms, fibrocytes, on day 15.
On day 2 after bleomycin administration, no FGA was seen but cytotoxic activity was detected in the BALF. On day 6, the cytotoxic activity was not found, whereas FGA showed a significantly higher level than the control value. On day 15, the FGA decreased to the control value.
Thrombin activity was significantly higher in the BALF from bleomycin-treated rats on days 2 and 6 than the control value, and decreased almost to the control value on day 15. The FGA of the BALF obtained on day 6 showed a significant decrease when pretreated with various thrombin inhibitors, such as α1-antitrypsin, antithrombin III, hirudin and MD-805. Purified rat thrombin showed FGA in the same assay, and its FGA was similary decreased by the thrombin inhibitors. Ammonium sulfate fractionation of the BALF showed that both FGA and thrombin activity were contained mainly in the fraction of 35-50% saturation.
These results indicate that the FGA in the BALF from bleomycin-treated rats may be partly due to thrombin, and that thrombin may be responsible, at least in part, for fibroblast growth and fibrosis in bleomycin-induced interstitial lung disorder.
View full abstract